Skip to main content
. 2022 Feb 11;102:1123. doi: 10.2340/actadv.v102.1123

Table IV.

Survival outcomes of patients with leukaemia cutis (LC)

AML ALL CML CLL MDS Total n (%)
Patients, n (%) 35 7 1 1 2 46 (84)
Duration, months, mean (range) 4.8 (0.5–12.6) 9.4 (0.1–40) 7.5 (7.5) 3.6 (3.6) 9.5 (1.1–17.8) 5.4 (0.1–40)

AML: acute myelogenous leukaemia; ALL: acute lymphoblastic leukaemia; CML: chronic myeloid leukaemia; CLL: chronic lymphocytic leukaemia; MDS: myelodysplastic syndrome.